All the Data, Tools, and Care in One Psychedelic Platform

Your One-Stop Connection to Psychedelics

Our technology collects and analyzes data so that you don't have to Our team researches industry updates to keep you in the know Leverage tools that can be customized for your business Find and book clinics, therapists, coaches, and retreats Connect with industry professionals to help grow the industry

Signup Request Data

Or learn more about Neuly

Who is Neuly For?

Entrepreneurs, investors, researchers, scientists, educators, policy makers, and anyone interested in the psychedelics industry.

Find an industry professional

Find a new job

Find investments

Join an event

Explore research

View insights

Join today to get access to our extensive psychedelic database + your Neuly dashboard to follow & save info, take notes, and more.


Recent Job Postings

Research Program Supervisor

Jul 01, 2022

Baltimore, Maryland, USA

Full Time

Psychiatric Mental Health Nurse Practitioner (PMHNP)

Jun 15, 2022


Full Time


Psychiatric Mental Health Nurse Practitioner (Remote)

Jun 15, 2022


Full Time


Browse All Jobs

Upcoming Events

Taboo No More

Jul 26, 2022

Psychedelic & Indigenous Medicine Retreat with Floresta New York

Jul 28, 2022

New York, USA

Ketamine, Therapy

Investor Hotseat #6 w/ Greg Roufa

Aug 04, 2022


Browse All Events

Recruiting Clinical Trials in Psychedelics

Interested in participating in a clinical trial as a patient or healthy volunteer? Browse, filter, and search through 183 clinical trials that are actively recruiting to find a match for you.

View Recruiting Clinical Trials

Top 3 Trending News

Psychedelics Market Update: H1 2022 in Review - Investing News Network

Jul 20, 2022 – The psychedelics industry has suffered during 2022's macroeconomic downturn, but experts point to its long-term outlook as a source of optimism.

Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues ...

Jul 20, 2022 – Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications.

Psilocybin / MDMA

Home Office plan to punish cannabis and MDMA users is 'de facto decriminalisation', say ... - iNews

Jul 19, 2022 – Under the proposed plans, casual users of illegal drugs such as cocaine, MDMA and cannabis could be fined or forced to pay for and attend a drug ...


Browse All News

Non-Profits by Focus

Explore Non-Profits

Organizations by Type

Explore Organizations

Neuly Insights

Register for your free account to get access to all Neuly Insights.

Join Neuly

Investment Funds & Organizations

View Investment Funds

Organizations By Drug Focus

Explore by Focus

Top 10 Locations for People

Explore Locations

How Neuly Can Help You

We've made complicated data and information easy to understand.


Find high-quality, low-cost solutions for your start up.


Share your findings with a dedicated network of experts.


Stay up to date about company progress with alerts.


Provide your students with the most relevant information.


Stop hunting for information across multiple platforms.


Access a deep database of resources.

Policy Makers

Understand industry data to help you make informed decisions.

Join Neuly

Transparent information for entrepreneurs, investors, researchers, scientists, educators, policy makers, and anyone interested in the psychedelic industry.

Terms of Use | Privacy Policy | © 2022 Neuly

Request Listing

Jobs Report

We're Hiring!


Organizations People Research Locations Focus Events Jobs Clinical Trials Pubco Index Investors Insights Helpful Links About Neuly What Data is Included Create a Profile Coming soon! Dashboard Help Register / Login